ArticleDiabetes & vascular disease research

Renoprotective effects of combination treatment with sodium-glucose cotransporter inhibitors and GLP-1 receptor agonists in patients with type 2 diabetes mellitus according to preceding medication.

Kazuo Kobayashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.